Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up.
J Am Acad Dermatol. 2023 Dec;89(6):1149-1158. doi: 10.1016/j.jaad.2023.07.1024. Epub 2023 Aug 6.
J Am Acad Dermatol. 2023.
PMID: 37553030
Free article.
Clinical Trial.
Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis.
Armstrong AW, Soliman AM, Betts KA, Wang Y, Gao Y, Stakias V, Puig L.
Armstrong AW, et al. Among authors: stakias v.
Dermatol Ther (Heidelb). 2022 Jan;12(1):167-184. doi: 10.1007/s13555-021-00647-0. Epub 2021 Dec 4.
Dermatol Ther (Heidelb). 2022.
PMID: 34862951
Free PMC article.
Item in Clipboard
A Response to: Letter to the Editor Regarding Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis.
Armstrong AW, Soliman AM, Betts KA, Wang Y, Gao Y, Stakias V, Puig L.
Armstrong AW, et al. Among authors: stakias v.
Dermatol Ther (Heidelb). 2022 Dec;12(12):2867-2870. doi: 10.1007/s13555-022-00812-z. Epub 2022 Oct 21.
Dermatol Ther (Heidelb). 2022.
PMID: 36271222
Free PMC article.
No abstract available.
Item in Clipboard
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse).
Stein Gold LF, Bagel J, Tyring SK, Hong HC, Pavlovsky L, Vender R, Pinter A, Reich A, Drogaris L, Wu T, Patel M, Soliman AM, Photowala H, Stakias V, Richter S, Papp KA.
Stein Gold LF, et al. Among authors: stakias v.
Br J Dermatol. 2023 Oct 25;189(5):540-552. doi: 10.1093/bjd/ljad252.
Br J Dermatol. 2023.
PMID: 37488811
Clinical Trial.
Item in Clipboard
Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris.
Kircik L, Del Rosso JQ, Weiss JS, Stakias V, London A, Keynan R, Hazot Y, Elliott R, Stuart I.
Kircik L, et al. Among authors: stakias v.
J Clin Aesthet Dermatol. 2020 Apr;13(4):14-21. Epub 2020 Apr 1.
J Clin Aesthet Dermatol. 2020.
PMID: 33144907
Free PMC article.
Item in Clipboard
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Carter K, Stakias V, Lippe R, Drogaris L, Soliman AM, Chen MM, Padilla B, Kivitz A.
Östör A, et al. Among authors: stakias v.
Rheumatol Ther. 2024 Jun;11(3):633-648. doi: 10.1007/s40744-024-00657-2. Epub 2024 Mar 18.
Rheumatol Ther. 2024.
PMID: 38498139
Free PMC article.
Item in Clipboard
Cite
Cite